These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 24800945)
21. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog. De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606 [TBL] [Abstract][Full Text] [Related]
23. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity. Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962 [TBL] [Abstract][Full Text] [Related]
24. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin. Holzer AK; Manorek GH; Howell SB Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145 [TBL] [Abstract][Full Text] [Related]
25. NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells. Jiang P; Wu X; Wang X; Huang W; Feng Q Oncotarget; 2016 Jul; 7(28):43337-43351. PubMed ID: 27270317 [TBL] [Abstract][Full Text] [Related]
26. Role of the copper transporter, CTR1, in platinum-induced ototoxicity. More SS; Akil O; Ianculescu AG; Geier EG; Lustig LR; Giacomini KM J Neurosci; 2010 Jul; 30(28):9500-9. PubMed ID: 20631178 [TBL] [Abstract][Full Text] [Related]
27. Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference. Ansbro MR; Shukla S; Ambudkar SV; Yuspa SH; Li L PLoS One; 2013; 8(4):e60334. PubMed ID: 23593196 [TBL] [Abstract][Full Text] [Related]
28. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453 [TBL] [Abstract][Full Text] [Related]
29. Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain. Öhrvik H; Logeman B; Turk B; Reinheckel T; Thiele DJ J Biol Chem; 2016 Jul; 291(27):13905-13916. PubMed ID: 27143361 [TBL] [Abstract][Full Text] [Related]
30. Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells. Akerfeldt MC; Tran CM; Shen C; Hambley TW; New EJ J Biol Inorg Chem; 2017 Jul; 22(5):765-774. PubMed ID: 28516214 [TBL] [Abstract][Full Text] [Related]
31. Up-regulation of MDR1 function and expression by cisplatin in LLC-PK1 cells. Takara K; Tsujimoto M; Kokufu M; Ohnishi N; Yokoyama T Biol Pharm Bull; 2003 Feb; 26(2):205-9. PubMed ID: 12576681 [TBL] [Abstract][Full Text] [Related]
32. Molecular modulation of the copper and cisplatin transport function of CTR1 and its interaction with IRS-4. Tsai CY; Larson CA; Safaei R; Howell SB Biochem Pharmacol; 2014 Aug; 90(4):379-87. PubMed ID: 24967972 [TBL] [Abstract][Full Text] [Related]
33. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related]
34. Distinct mechanisms for Ctr1-mediated copper and cisplatin transport. Sinani D; Adle DJ; Kim H; Lee J J Biol Chem; 2007 Sep; 282(37):26775-26785. PubMed ID: 17627943 [TBL] [Abstract][Full Text] [Related]
35. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters. Samimi G; Howell SB Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571 [TBL] [Abstract][Full Text] [Related]
36. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library. Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344 [TBL] [Abstract][Full Text] [Related]
37. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines. Fujimoto H; Higuchi M; Watanabe H; Koh Y; Ghosh AK; Mitsuya H; Tanoue N; Hamada A; Saito H Biol Pharm Bull; 2009 Sep; 32(9):1588-93. PubMed ID: 19721237 [TBL] [Abstract][Full Text] [Related]
38. Decreased Expression of the Haberkiewicz O; Lipiński P; Starzyński RR; Jończy A; Kurowska P; Ogórek M; Bednarz A; Herman S; Hatala D; Grzmil P; Rajfur Z; Baster Z; Lenartowicz M Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232742 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells. Hall MD; Salam NK; Hellawell JL; Fales HM; Kensler CB; Ludwig JA; Szakács G; Hibbs DE; Gottesman MM J Med Chem; 2009 May; 52(10):3191-204. PubMed ID: 19397322 [TBL] [Abstract][Full Text] [Related]